thickness reduction of the ganglion cell-inner plexiform layer best discriminates prior optic neuritis in patients with multiple sclerosis. Invest Ophthalmol Vis Sci. 2019;60:4257-4269. https://doi.org/10.1167/ iovs.19-27574 PURPOSE. The goal was to visualize topographic thickness maps of the intraretinal layers and evaluate their discrimination abilities and relationships with clinical manifestations in patients with multiple sclerosis (MS) and a history of optic neuritis (ON).
M ultiple sclerosis (MS), affecting more than 2.3 million people worldwide, is a chronic autoimmune neurological disorder of the central nervous system. 1 Early diagnosis and treatment may stop or reverse the disease progression. 2 Current imaging diagnostic criteria include lesions of the brain and spine, but not the optic nerve. 3 Clinical and subclinical optic neuritis (ON) are highly prevalent during the MS disease course, [3] [4] [5] and image markers for ON are in development. The eye is a window to the brain. Thinning of the peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell-inner plexiform layer (GCIPL) as measured in vivo using spectraldomain optical coherence tomography (SD-OCT) represent optic nerve damage and correlate with neurodegeneration, therapeutic efficacy, and disease progression. [6] [7] [8] [9] [10] Recent studies suggested that intereye pRNFL and GCIPL thickness differences [11] [12] [13] identified a history of unilateral ON, which may demonstrate optic nerve lesions in patients with MS and facilitate the diagnosis. However, intereye thickness differences only provide moderate discrimination power and identify approximately 70% of ON from healthy controls (HC). 11, 13, 14 This low sensitivity may be due to the drawbacks in the intereye approach. To use the intereye thickness difference method, the criterion of unilateral ON must be predetermined. However, it is hard to exclude subclinical ON clinically, which occurs with high incidence in patients with MS. [3] [4] [5] The averaged thicknesses of the GCIPL and pRNFL that are used in intereye approaches 11, 13, 14 may not be sensitive enough to identify optic nerve damage. Because the distribution of the neural fiber and ganglion cells are not even, [15] [16] [17] and the alterations in these neural layers are not even. 15, 16 The average thicknesses of these layers using arbitrary partitions, such as the elliptical partition, which is commonly used in the clinic, may not well define the focal thickness alterations 11, 13, 14 and could render the moderate discrimination power when using the intereye thickness difference approach.
The visualization and quantitative analysis of topographic thickness patterns of intraretinal layers may identify the most profound focal thickness alterations and help in the development of sensitive markers of prior ON in patients with MS. A previous study of MS patients without a history of ON (MSNON) reported that the most profound thickness alteration was located in the inferior nasal area of the GCIPL, named the ''M Zone,'' and provided the highest discrimination power and strongest correlations to visual function and disease disability. 15 However, whether eyes with a history of ON in patients with MS share similar thickness patterns is not known. The purpose of the present study was to visualize the topographic thickness patterns of intraretinal layers and evaluate their discrimination performance and relationships with clinical manifestations in patients with MS and a history of ON.
METHODS

Participants
Thirty patients with relapsing-remitting MS and a history of ON were recruited (Table 1) 18 There were a total of 34 eyes that had a history of ON (MSON) and 26 non-ON fellow eyes (MSFE). Four of the 30 patients had a history of bilateral ON. A total of 126 eyes from 63 age-and sex-matched healthy subjects were imaged as HC. The following exclusion criteria were used: any other systemic, ocular, or neurological diseases; refractive errors > 6 6.0 diopters; or relapse within the past 6 months.
The Institutional Review Board of the University of Miami approved this study, and all study subjects were treated according to the tenets of the Declaration of Helsinki. Each participant signed written informed consent after the details of the study were explained. Each subject received a full eye examination, including bestcorrected visual acuity (BCVA), color vision, intraocular pressure (IOP), and slit-lamp biomicroscopy of anterior and posterior segments. Binocular low-contrast letter acuity (LCLA) was tested using the 2.5% and 1.25% of the LCLA charts (lowcontrast Sloan letter chart, Precision Vision, LaSalle, IL, USA) with the best possible correction for refractive errors. LCLA scores were quantified as the number of letters correctly read by the patient. 19 Most of the MS patients had a BCVA of 20/20 or above, normal color vision (tested using the Ishihara's color test), and confrontational visual field. However, the BCVA of one patient with bilateral ON was 20/40 bilaterally. Another patient had a BCVA of 20/50 for the MSON eye.
Topographic Thickness Maps of Intraretinal Layers Using Ultrahigh Resolution Optical Coherence Tomography (UHR-OCT)
As described previously, 16, 17, 20 the custom UHR-OCT system is a spectral domain OCT with an axial resolution of~3 lm in tissue and a scan speed of 24,000 A-scans per second. The scan pattern was a raster scan with 512 A-scans (per B-scan) 3 128 B-scans, which covered a field of view of 6 3 6 mm centered on the fovea. The scan data set was exported and segmented using an automatic image processing software program (Orion, Voxeleron LLC, Pleasanton, CA, USA). 17 Segmentation of all intraretinal layers of the horizontal scan (fast scan) and the vertical scan (slow scan) crossing the foveal center, and the thickness map of the total retina were exported and saved as a record for segmentation verification. However, the segmentation of each Bscan was not checked. The six segmented layers were the macular retinal nerve fiber layer (mRNFL), GCIPL, inner nuclear layer (INL), outer nuclear layer (ONL), outer plexiform layer (OPL), and retinal photoreceptor (PR). Total retinal thickness (TRT) was also recorded ( Fig. 1 ). 20, 21 The thickness measurements in annuli, quadrants, and sectors were exported using the Early Treatment Diabetic Retinopathy Study (ETDRS).
To visualize the topographical thickness pattern of each segmented intraretinal layer, thickness maps of each group were aligned using the center of the fovea and averaged. Maps of the left eyes were flipped horizontally and averaged with the maps of the right eyes. Differences between the thickness maps (i.e., 512 3 128 pixel array centered on the fovea) were calculated by subtracting the thickness maps of control eyes from the thicknesses of the MSON or MSFE eyes to create thickness alteration maps. 16 Visualization was rendered using MATLAB software (version 2014b, MathWorks, Natick, MA, USA).
Statistical Analyses
Statistical Package for the Social Sciences (SPSS; version 25, IBM, Armonk, NY, USA) and Statistical Academic (version 13; TIBCO Software, Inc., Palo Alto, CA, USA) were used to analyze the data. Data are presented as the means 6 standard error (SE). The sample size was calculated using a software program (Gpower, version 3.1.9). Based on the GCIPL thickness of the HC and MSON groups reported in previous studies, 11, 13, 14, 22 a sample size of 20 subjects in each group would be sufficient to detect a true difference (10 lm) in GCIPL thickness with a detection power of 0.95. The present study, 63 HC and 30 MSON were recruited, and ensured sufficient power. The present study focused on the visualization of topographic thickness alterations in intraretinal layers, and this sample may be sufficient to determine the true alterations in a focal area with the most profound alteration in thickness. Generalized estimating equation (GEE) models were used to quantify intercorrelation of eyes within subjects. Eyes (left or right) were set as within-subject variables. The thickness measurements including the GCIPL thickness of the U Zone were dependent variables. Age, sex, and eye were covariates in GEE models. In addition, disease duration and treatment (with and without treatment) were additional covariates in GEE models to analyze the differences between MSNON and MSON eyes. Relationships between thickness variables and clinical manifestations were analyzed using Pearson's correlation. P < 0.05 was considered statistically significant.
RESULTS
Topographic Thickness Maps of Intraretinal Layers
The topographic thickness maps of intraretinal layers showed an apparent trend of thickness reduction from HC to MSFE The schematic diagram shows the definition of the horseshoe shape of the thickness reduction, named as the ''U Zone.'' The horseshoe-like thickness reduction was defined as the ''U Zone'' with a portion of an elliptic annulus (dimensions: 1.45 and 3.5 mm for the inner and outer vertical diameters, respectively, and 1.8 and 4.9 mm for the inner and outer horizontal diameters, respectively) around the fovea. In contrast, MSFE showed an island pattern located on the nasal side (B). GCIPL thickness (C) and proportional thicknesses (D) of the U Zone exhibited significant reductions in MSON compared with MSFE and HC. Similar horseshoe-like thickness reduction patterns were also evident in the proportional thickness maps, which were calculated as (MSON-HC)/HC and (MSFE-HC)/HC. then MSON in the TRT, mRNFL, and GCIPL (Fig. 2) . The subtraction maps showed that the thickness reductions occurred in MSON and MSFE eyes in all intraretinal layers, except for the ONL (Fig. 3 ).
Thickness Reduction Patterns of the GCIPL
To visualize the patterns of thickness reduction, the areas of the GCIPL with thickness alterations were determined in the thickness subtraction maps using different cutoff threshold settings. A horseshoe-like thickness reduction pattern was found in MSON ( Fig. 4) . In contrast, MSFE showed an island pattern located on the nasal side. Similar horseshoe-like thickness reduction patterns were also evident in the proportional thickness maps, which were calculated as (MSON-HC)/HC and (MSFE-HC)/HC (Fig. 4) . The horseshoelike thickness reduction was defined as the ''U Zone'' with a portion of an elliptic annulus (dimensions: 1.45 and 3.5 mm for the inner and outer vertical diameters, respectively, and 1.8 and 4.9 mm for the inner and outer horizontal diameters, respectively) around the fovea. The GCIPL thickness of the U Zone exhibited a significant reduction in MSON compared with that of MSFE and HC.
Topographic Thickness Partition and Analysis
Analyses of the annuli (Fig. 5 ), quadrants ( Fig. 6 ), and sectors ( Fig. 7) using the ETDRS partition revealed significant thickness reductions in the TRT, mRNFL, and GCIPL in MSON compared with those of MSFE and HC in partitions using GEE models (P < 0.05). The mRNFL and GCIPL thicknesses of all partitions were thinner in MSFE than those of HC (P < 0.05). The thicknesses of TRT in all annuli, quadrants, sectors, except for sectors inner inferior (II), inner temporal (IT), and OI were thinner in MSFE eyes than HC eyes (P < 0.05). Thickness alterations of the INL, OPL, outer nuclear layer (ONL), and PR were also found (Figs. 5-7).
Discrimination Power
The area under the receiver operating characteristic curve (AUC) was analyzed via counting a single eye and both eyes of each subject. The discrimination power of the GCIPL thickness in the U Zone was compared with the ETDRS partitions and the M Zone, which was previously defined in MS eyes without a history of ON. 15 The previously defined 15 M zone was located at nasal 1.98 mm and inferior 0.42 mm from the fovea with a circular area (Fig. 8) . When a single eye for each group was counted, the GCIPL thickness of the U Zone had the best (Fig. 8) . In contrast, the M Zone had the best discrimination power (AUC ¼ 0.81, sensitivity ¼ 0.81, specificity ¼ 0.69, with cutoff ¼ 84.0 lm) in discriminating MSFE from HC eyes (Fig. 8) .
Analyses of the intereye differences in patients with a history of unilateral ON revealed that the thickness of the GCIPL in the nasal quadrant (GCIPL_N) had the best discrimination power (AUC ¼ 0.86, sensitivity ¼ 0.65, specificity ¼ 0.92, with cutoff ¼ 5.4 lm) in discriminating patients with MS and history of unilateral ON from HC, and the U Zone was ranked second, with a discrimination power of 0.85 (sensitivity ¼ 0.69, specificity ¼ 0.97, with cutoff ¼ 6.2 lm). However, the M Zone was ranked 13th with a discrimination power of 0.79 (sensitivity ¼ 0.77, specificity ¼ 0.81, with cutoff ¼ 7.1 lm) ( Fig. 8) .
Scatter plots of GCIPL thicknesses in the U Zone showed that the optimal cutoff discriminated all MSON eyes, except one eye ( Fig. 9 ). However, MSFE were distributed on both sides of the cutoff. In contrast, the scatter plot of the intereye differences of the GCIPL in the U Zone in MS patients with a history of unilateral ON showed a moderate discrimination power to identify MS patients and exclude HC. Application of the optimal cutoff of GCIPL thickness in the U Zone discriminated 16 eyes of the 26 MSFE eyes (62%) as MSON eyes.
Correlations Between OCT Measurements and Clinical Manifestations
The thickness of the U Zone was positively related to 2.5% LCLA (r ¼ 0.38, P < 0.05) and 1.25% LCLA (r ¼ 0.57, P < 0.05) in MS patients, which was slightly weaker compared with the GCIPL thickness in the inner superior sector (IS) (Fig. 10) . The GCIPL thickness of the M Zone was significantly correlated to the Expanded Disability Status Scale (EDSS) (r ¼ À0.39, P < 0.05). However, there were no significant relationships between disease duration and the OCT thickness measurements (r ranged from À0.20 to À0.14, P > 0.05).
DISCUSSION
This study was aimed to visualize topographic retinal thickness maps in patients with MS and a history of ON, and to evaluate their discrimination performance and relationships with clinical manifestations. The results of this study showed that thickness alterations of the GCIPL in the U Zone appeared to be specific to MSON eyes, which described the most profound thickness alternation, and had the highest discrimination power and was positively correlated with LCLA. Therefore, the characteristic pattern of the GCIPL may be developed as an image marker for determining the history of ON as the evidence of damage to the optic nerve in MS. With the cutoff of 82.3-lm (equivalent to 4.5-lm thickness reduction), up to 97% of MSON eyes were discriminated from HC, which is a robust threshold for identifying optic lesions. This threshold may also be beneficial in identifying possible asymptomatic subclinical optic nerve lesions. The inclusion of optic nerve lesions as a site for imaging criteria for the diagnosis of MS is considered a high priority area for research by the magnetic resonance imaging in the MS study group. 23 Further validation using a large-scale study may be proved useful as a new add-on criterion for the diagnosis of MS.
The thickness alternations of the U Zone were found in MSON eyes based on the pattern and magnitude of the alteration. A profound change of up to 21 lm on average was typical, which is higher than the average change in the inner annulus defined by the commonly used elliptical zone (À16.4 lm) according to a meta-analysis of multiple studies. 24 Therefore, the change in GCIPL thickness of an individual eye may be sufficient to establish the presence of optic nerve lesions in MS, as shown in the present and previous studies. 22, 24, 25 In addition to the magnitude of the thickness reduction, the location of the changes may also be specific. The focal thickness reduction zone in the intraretinal layers generally represents the area that is most seriously affected by certain diseases (Table 2) . 15, 16, [26] [27] [28] [29] [30] [31] [32] [33] Different thickness reduction patterns were documented in different systemic conditions, such as Alzheimer's disease, 16 and ocular disorders, such as glaucoma. [26] [27] [28] These characteristic patterns often provide disease-specific information and better discrimination powers compared with averaged thickness. [27] [28] [29] Inferotemporal thinning of the GCIPL is reported in patients with glaucoma, 30 and inferonasal thinning of GCIPL is reported in patients with ethambutol-induced optic neuropathy. 26 Inferonasal and superonasal thinning of the GCIPL were reported in optic chiasmal compression caused by a pituitary adenoma. 28 A superior thinning of the GCIPL was also reported in patients with Alzheimer's disease. 16 Although the thickness alteration in the U Zone may be used to diagnose ON, whether the U Zone is specific to MSON remains untested since no other diseases were compared in the present study.
A previously published study demonstrated that focal thickness reduction in patients with MS and no history of ON was limited to a small zone in the nasal-inferior region, named the M Zone. 15 A similar M Zone existed in MSFE eyes, and the thickness reduction zone expanded to a horseshoeshaped region in MSON eyes. The similarities in the thickness reductions (e.g., horseshoe shape with the small thickness deductions shown in Fig. 4B ) with a much smaller scale in MSFE eyes also support the speculation, but much more profound alterations were observed in the MSON eyes. This result indicates that the specific topographic thickness patterns may be used to identify neural damage due to ON in patients with MS and may be used to determine possible subclinical ON. The present study observed topographic changes between MSFE and MSON eyes, such as focal thickness reductions of the GCIPL in the M Zone and U Zone, respectively. Acute ON causes a profound but heterogeneous thinning of intraretinal layers in patients with MS, 24 which indicates extensive damage of the ganglion cells due to local optic nerve inflammation. This damage may explain why the focal thinning zone expanded from a circular area (i.e., the M Zone) to a horseshoe-shaped area (i.e., the U Zone). The reduction in the U Zone occurred almost completely in the annulus, where the thickest GCIPL band between the inner and outer annuli exists. The reduction was not proportional to the baseline thickness of the HC eyes, which may indicate that the U Zone is a vulnerable region to ON damage. Whereas the M Zone had the best performance in differentiating eyes with MSFE from HC, and it was similar to MSNON eyes, 15 which may indicate that MSFE and MSNON share similar characteristics of focal thickness reduction and may be at similar disease stages. The focal thinning of the GCIPL in the M Zone in MSFE eyes echoes previous findings that mitochondrial dysfunction contributes to MS pathophysiology. [34] [35] [36] Furthermore, the location of the M Zone is similar to the focal thinning of the GCIPL from mitochondrial optic neuropathies, 37, 38 and smaller axons were more profoundly damaged in patients with MS. 39, 40 The M Zone thickness negatively correlated to EDSS in patients with MSON, with an r value of 0.39, which was less than MSNON (r ¼ 0.59) found in our previous study. 15 This phenomenon echoes the findings that the pRNFL and GCIP thicknesses derived from eyes with a history of ON may correlate less with brain or brain-substructure volumes than eyes without a previous history of ON. 9, [41] [42] [43] In clinical practice, due to excellent visual function recovery, including visual acuity and visual fields, the prior ON is sometimes not confirmed. Also, subclinical optic neuropathy due to the diffuse demyelination that is present in MS 5 may result in a similar degree of average thinning of the pRNFL and GCIPL compared with MSON eyes. The intereye variability of pRNFL and GCIPL thicknesses were reported to have better discrimination power to identify possible prior ON (Table 3) . 3, 11, 12, 14 However, the threshold criteria of the intereye differences only exhibited moderate discrimination powers, except for the study of Xu et al. 12 Using 6 lm derived from 99th percentile of a normal population (233 subjects), Xu et al. 12 reported 96% sensitivity to determine prior ON in mixed patients including MS (51%), idiopathic (41%), and neuromyelitis optica spectrum disorder (8%). Because of the mixed etiology of ON, the cutoff and its associated sensitivity may not be recommended as a routine tool for diagnosing ON in patients with MS. 3 However, a recent international study reported an optimal intereye difference threshold of the GCIPL for identifying prior unilateral ON, 13 and the sensitivity of a 4lm cutoff of GCIPL yielded similar results in previous studies. 11, 14 Coric et al. 11 studied intereye GCIPL percentage difference normalized to the absolute thickness level of retinal layers and found that a 6% intereye difference in the GCIPL had 62% sensitivity. Nolan et al. 13 reported a 4-lm intereye GCIPL difference to identify prior ON based on a large sample size (477 patients with unilateral ON and 253 HC subjects). The intereye difference (4 lm) of the U Zone thickness provided a 73% sensitivity in the present study, and the cutoff of 3 lm of the U Zone thickness provided 77% sensitivity, which are slightly better than previous studies, 11, 13, 14 except for the study of Xu et al. 12 Notably, the moderate sensitivity of the GCIPL in determining prior ON may be due to the ubiquitous occurrence of subclinical ON, which is often asymptomatic. 3 Approximately one-third of patients with MS with intereye differences greater than 4 lm reported no history of ON. These patients may have subclinical ON. If subclinical ON occurred in the fellow eyes, the intereye differences may be diminished, which may explain our finding that approximately 6-fold of fellow eyes had GCIPL thickness in the U Zone below the cutoff value (i.e., 82.3 lm or reduction 4.5 lm compared with HC). Therefore, combining the cutoff of the GCIPL of individual eyes and the cutoff of intereye thickness difference is recommended for identifying optic nerve lesions, including subclinical optic nerve pathology.
There are several limitations to the present study. First, although MSON in our study had a history of ON, we do not know whether the fellow eye had subclinical ON. Second, our study used a custom-built UHR-OCT, which is not used in routine clinics. Although the axial resolution (i.e.,~3 lm) of our UHR-OCT is higher than most commercial OCT devices (commonly~5 lm), the scan speed is 24 Khz, which is slower than currently commercial OCT devices (i.e., 70-100 Khz). Further update of the scan speed in our system is needed. Furthermore, the results obtained from the custom built UHR-OCT may limit the generalization of our current findings. However, the Orion Software used in the present study has been adapted in commercial OCT devices such as Zeiss Cirrus HD-OCT (with special data exportation), 44, 45 Topcon 3D-1000 (Topcon Medical Systems, Inc., Oakland, NJ, USA), 46 and Spectralis SD OCT (Heidelberg Engineering, Heidelberg, Germany). 47 Our study can be repeated using these commercial OCT devices and the Orion software. [44] [45] [46] [47] In addition, the visualized thickness reduction patterns may provide a reference for the clinical interpretation of OCT images using clinically available OCT devices. Third, the segmentation of intraretinal layers of each B-scan of the volumetric data set was not verified by the investigators, which constitutes a limitation. Visual inspection and possible manual correction of each Bscan may help reduce the segmentation errors. Fourth, the sample size was small, compared with recent studies involving hundreds of patients, [11] [12] [13] which may cast a risk of bias. However, the visualization of the focal alteration of topographic thicknesses in patients with ON may provide useful information for designing future independent population based studies to refine the topographic alteration of the intraretinal layers in patients with ON. Fifth, we did not perform follow-up of these patients. Longitudinal studies may further reveal the time course of focal thinning.
In conclusion, the horseshoe-like thickness reduction of the GCIPL appeared to be an ON-specific focal thickness alteration with the highest discrimination power of MSON. The characteristic changes may represent the vulnerable regions affected by ON in patients with MS and may be developed into an image marker for the diagnosis of prior ON. 
